Honokiol inhibits vascular vessel formation of mouse embryonic stem cell-derived endothelial cells via the suppression of PECAM and MAPK/mTOR signaling pathway

Cellular Physiology and Biochemistry

Volumn 30, Issue 3, 2012, Pages 758-770

  Kim, Gi Dae ^a   Bae, Song Yi ^a   Park, Hyun Joo ^a   Bae, Kihwan ^b   Lee, Sang Kook ^a  

^a Seoul National University   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Anti angiogenesis; Differentiation; Honokiol; MAPK; Mouse embryonic stem cells; MTOR; PECAM

Indexed keywords

CD31 ANTIGEN; COLLAGEN GEL; GELATIN; HONOKIOL; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG INHIBITION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; GROWTH INHIBITION; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; VASCULARIZATION; WESTERN BLOTTING;

EID: 84865272951     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000341455     Document Type: Article

References (48)

1. Evans MJ, Kaufman MH: Establishment in culture of pluripotential stem cells from mouse embryos. Nature 1981;291:154-156.
2. Rathjen PD, Lake J, Whyatt LM, Bettess MD, Rathjen J: Properties and uses of embryonic stem cells: Prospects for application to human biology and gene therapy. Reprod Fertil Dev 1998;10:31-47.
3. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R: The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 1985;87:27-45.
4. Risau W, Sariola H, Zerwes HG, Sasse J, Ekblom P, Kemler R, Doetschman T: Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 1988;102:471-478.
5. Li X, Claesson-Welsh L: Embryonic stem cell models in vascular biology. J Thromb Haemost 2009;1:53-56.
6. Jakobsson L, Kreuger J, Holmborn K, Lundin L, Eriksson I, Kjellén L, Claesson-Welsh L: Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev Cell 2006;10:625-634.
7. Kawamura H, Li X, Goishi K, van Meeteren LA, Jakobsson L, Cébe-Suarez S, Shimizu A, Edholm D, Ballmer-Hofer K, Kjellén L, Klagsbrun M, Claesson-Welsh L: Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood 2008;112:3638-3649.
8. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J: flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 1993;118:489-498.
9. Redick SD, Bautch VL: Developmental platelet endothelial cell adhesion molecule expression suggests multiple roles for a vascular adhesion molecule. Am J Pathol 1999;154:1137-1147.
10. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
11. Sakurai Y, Ohgimoto K, Kataoka Y, Yoshida N, Shibuya M: Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Natl Acad Sci USA 2005;102:1076-1081.
12. Kanno S, Oda N, Abe M, Terai Y, Ito M, Shitara K, Tabayashi K, Shibuya M, Sato Y: Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 2000;19:2138-2146.
13. Meadows KN, Bryant P, Vincent PA, Pumiglia KM: Activated Ras induces a proangiogenic phenotype in primary endothelial cells. Oncogene 2004;23:192-200.
14. Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, Dubiel W, Soff G, Arbiser JL: Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 2003;278:35501-35507.
15. Wu G, Luo J, Rana JS, Laham R, Sellke FW, Li J: Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res 2006;69:512-519.
16. Foster KG, Acosta-Jaquez HA, Romeo Y, Ekim B, Soliman GA, Carriere A, Roux PP, Ballif BA, Fingar DC: Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. J Biol Chem 2010;285:80-94.
17. Hwang M, Perez CA, Moretti L, Lu B: The mTOR signaling network: insights from its role during embryonic development. Curr Med Chem 2008;15:1192-1208.
18. Sparks CA, Guertin DA: Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 2010;29:3733-3744.
19. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L: VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 2006;5:359-371.
20. Benjamin LE, Keshet E: Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 1997;94:8761-8766.
21. Delisser HM, Baldwin HS, Albelda SM: Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1/CD31): A Multifunctional Vascular Cell Adhesion Molecule. Trends Cardiovasc Med 1997;7:203-210.
22. Vittet D, Prandini MH, Berthier R, Schweitzer A, Martin-Sisteron H, Uzan G, Dejana E: Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 1996;88:3424-3431.
23. Newman PJ: The biology of PECAM-1. J Clin Invest 1997;99:3-8.
24. Kim GD, Kim GJ, Seok JH, Chung HM, Chee KM, Rhee GS: Differentiation of endothelial cells derived from mouse embryoid bodies: a possible in vitro vasculogenesis model. Toxicol Lett 2008;180:166-173.
25. Kim GD, Rhee GS, Chung HM, Chee KM, Kim GJ: Cytotoxicity of 5-fluorouracil: Effect on endothelial differentiation via cell cycle inhibition in mouse embryonic stem cells. Toxicol In Vitro 2009;23:719-727.
26. Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK: The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 2003;475:19-27.
27. Park EJ, Zhao YZ, Na M, Bae K, Kim YH, Lee BH, Sohn DH: Protective effects of honokiol and magnolol on tertiary butyl hydroperoxide-or D-galactosamine-induced toxicity in rat primary hepatocytes. Planta Med 2003;69:33-37.
28. Hu H, Zhang XX, Wang YY, Chen SZ: Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin. Acta Pharmacol Sin 2005;26:1063-1068.
29. Matsui N, Takahashi K, Takeichi M, Kuroshita T, Noguchi K, Yamazaki K: Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice. Brain Res 2009;1305:108-117.
30. Xu Q, Yi LT, Pan Y, Wang X, Li YC, Li JM: Antidepressant-like effects of themixture of honokiol andmagnolol fromthe barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:715-725.
31. Munroe ME, Arbiser JL, Bishop GA: Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J Immunol 2007;179:753-763.
32. Kuo DH, Lai YS, Lo CY, Cheng AC, Wu H, Pan MH: Inhibitory effect of magnolol on TPA-induced skin inflammation and tumor promotion in mice. J Agric Food Chem 2010;58:5777-5783.
33. Nagase H, Ikeda K, Sakai Y: Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. invasiveness in vitro. Planta Med 2001;67:705-708.
34. Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB: Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res 2006;4:621-633.
35. Hibasami H, Achiwa Y, Katsuzaki H, Imai K, Yoshioka K, Nakanishi K, Ishii Y, Hasegawa M, Komiya T: Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells. Int J Mol Med 1998;2:671-673.
36. Wang T, Chen F, Chen Z, Wu YF, Xu XL, Zheng S, Hu X: Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol 2004;10:2205-2208.
37. Lee DH, Szczepanski MJ, Lee YJ: Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. J Cell Biochem 2009;106:1113-1122.
38. Heuer J, Bremer S, Pohl I, Spielmann H: Development of an in vitro embryotoxicity test using murine embryonic stem cell cultures. Toxicol In Vitro 1993;7:551-556.
39. Scholz G, Pohl I, Genschow E, Klemm M, Spielmann H: Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tissues Organs 1999;165:203-211.
40. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 1995;270:27489-27494.
41. Vlahos CJ, Matter WF, Hui KY, Brown RF: A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994;269:5241-5248.
42. Yang SE, Hsieh MT, Tsai TH, Hsu SL: Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem Pharmacol 2002;63:1641-1651.
43. Hu J, Chen L, Liu L, Chen X, Chen P, Yang G, Hou W, Tang M, Zhang F, Wang X, Zhao X, Wei Y: Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Exp Mol Med 2008;40:617-628.
44. Yue W Pi QM, Zhang WJ, Zhou GD, Cui L, Liu W, Cao Y: Platelet endothelial cell adhesion molecule-1, stage-specific embryonic antigen-1, and Flk-1 mark distinct populations of mouse embryonic stem cells during differentiation toward hematopoietic/endothelial cells. Stem Cells Dev 2010;19:1937-1948.
45. Cho DH, Choi YJ, Ahn JS, Ryou J, Kim JY, Chung J, Jo I: Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition. Am J Physiol Cell Physiol 2006;291:C317-C326.
46. He L, Wu Y, Lin L, Wang J, Wu Y, Chen Y, Yi Z, Liu M, Pang X: Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway. Cancer Sci 2011;102:219-225.
47. Dong Y, Lu B, Zhang X, Zhang J, Lai L, Li D, Wu Y, Song Y, Luo J, Pang X, Yi Z, Liu M: Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway. Carcinogenesis 2010;31:2097-2104.
48. Strömblad S, Becker JC, Yebra M, Brooks PC, Cheresh DA: Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. J Clin Invest 1996;9:426-433.